Kirk Nicholas Campbell, MD
Renal Electrolyte and Hypertension
Accepting new patients
Sees patients age 18 and up
Penn Renal Electrolyte and Hypertension Perelman
Penn Medicine Provider
About me
- Chief, Division of Renal-Electrolyte and Hypertension
- C. Mahlon Kline Professor
My education and training
- Residency: Yale-New Haven Hospital
- Fellowship: Mount Sinai Medical Center
Spoken languages
English
English
Insurance accepted
Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.
- Aetna Advantra Cares D-SNP
- Aetna Advantra Credit Value
- Aetna Advantra Eagle HMO
- Aetna Advantra Eagle POS
- Aetna Advantra Premier Plus PPO
- Aetna Advantra Value
- Aetna Advantra Value Plus
- Aetna APCN Plus (Multi-Tier)
- Aetna Better Health Kids (CHIP) - DH Only
- Aetna Flexible Five
- Aetna Freedom Core
- Aetna Gold
- Aetna HMO
- Aetna Philly Prime
- Aetna POS
- Aetna PPO APCN
- Aetna Premier
- Aetna Premier Plus
- Aetna Savings Plus
- Aetna Signature Administrators
- Aetna Student Health Plan PPO
- Aetna Upfront Advantage
- First Health HMO
- First Health POS
- First Health PPO
- Meritain - Aramark (Other)
- Meritain - Aramark (Pennsylvania Premier Medical Plan)
- Americhealth Caritas of PA VIP - LGH Only
- Amerihealth Caritas (Transplant patients only)
- Amerihealth Caritas of PA - LGH Only
- Centivo EPO
- Cigna Healthcare EPO
- Cigna Healthcare HMO
- Cigna Healthcare POS
- Cigna Healthcare PPO
- Claim Watcher (Homestead/ INDECs) Open Access
- Clover Health Choice
- Clover Health Choice Value PPO
- Clover Health Classic HMO
- Clover Health Value
Locations
Penn Medicine hospital privileges
- Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
- Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Campbell is a Penn Medicine physician.
Qualifications and experience
- Nephrology, 2006
- American Society of Nephrology Board Review Course and Update Faculty, National
- American Society of Nephrology Kidney Week Program Committee, National
- Council of Faculty and Academic Societies, Association of American Medical Colleges, National
- Department of Defense Peer Reviewed Medical Research Program (PRMRP), National
- Membership and Accreditation Committee of the International Society of Glomerular Disease, International
- National Kidney Foundation, National
- National Kidney Foundation of Greater New York, Local
- Nephcure Foundation, National
- New York Society of Nephrology, Local
- NIH/NIDDK DDK-D, National
- NIH/NIDDK Strategic Working Group – subgroup on biological pathways and contributors to health and disease, National
Treatments and conditions
Research
Publications
Mohandes S, Nast CC, Mottl A, Scialla J, Almaani S, Luciano R, Isakova T, Ellis C, Bansal S, Argyropoulos C, Jennette JC, Gasim A, Stillman IE, Campbell KN, Abedini A, Coppock G; TRIDENT Consortium; Susztak K, Palmer MB. Improving the Histologic Classification of Advanced Diabetic Nephropathy Based on the Transformative Research in Diabetic Nephropathy (TRIDENT) Findings , Kidney Int: 2026
Mohandes S, Fakhreddine M, Sheng H, Al Dulaimee M, Mottl A, Scialla J, Almaani S, Luciano R, Isakova T, Bansal S, Argyropoulos C, Avasare R, Singh M, Campbell KN, Townsend R, Coppock G, Palmer M, Susztak K; TRIDENT Consortium. Percutaneous Native Kidney Biopsy Complications in Diabetic Patients in the TRIDENT Cohort , Clin J Am Soc Nephrol, 21: 2026,1376-1385
Heerspink HJL, Arnott C, Barratt J, Campbell KN, Pecoits-Filho R, Fukami K, Halimi JM, Hou FF, Lam CSP, Levin A, Lindberg M, Kashioulis P, Mercier AK, Sinsakul M, Ambery P, Perkovic V. Design and baseline characteristics of the ZENITH high proteinuria trial testing zibotentan/dapagliflozin efficacy in CKD , Nephrol Dial Transplant: 2026
Vasquez-Rios G, Chauhan K, Naik N, Pattharanitima P, Chan L, Campbell KN, Nadkarni GN, Coca SG. Beyond Genotype: Multidomain Biomarker-Integrated Risk Scores Reveal Prognostic phenotypes Among Individuals with High-Risk APOL1 Genotypes , medRxiv: 2026
Lafayette R, Barbour SJ, Brenner RM, Campbell KN, Doan T, Eren N, Floege J, Jha V, Kim BS, Liew A, Maes B, Pal A, Pecoits-Filho R, Phoon RKS, Rizk DV, Suzuki H, Tesař V, Trimarchi H, Wei X, Zhang H, Barratt J; ORIGIN Phase 3 Trial Investigators. A Phase 3 Trial of Atacicept in Patients with IgA Nephropathy , N Engl J Med, 394: 2026,647-657
Floege J, Ayoub I, Brix SR, Campbell KN, Furie R, Nachman PH, Tang SCW, Tomas NM, Vivarelli M, Cheung M, King JM, Grams ME, Jadoul M, Rovin BH; Conference Participants. Targeting B cells in immune-mediated kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference , Kidney Int: 2026
Fischman CJ, Zee J, Campbell KN. Family Matters: Dissecting the Impact of Family Medical History, APOL1 Genotype, and Sociodemographic Factors on CKD Progression in the Chronic Renal Insufficiency Cohort (CRIC) Study , Am J Kidney Dis: 2026
Yu L, Ekperikpe US, Korsmo HW, Zhao S, Yi Z, Haydak J, Lefferts S, Meliambro K, Campbell KN, Azeloglu EU, Kohan DE, McCown PJ, Naik AS, Otto EA, Haraldsson B, Zhang W, Daehn IS. Podocyte-derived endothelin-1 and endothelial cell endothelin A receptors are essential for glomerular injury in mouse models of focal segmental glomerulosclerosis , Kidney Int: 2026
Wong JS, Campbell KN. Communication leading to injury: podocyte-derived fibrillin-1 induces mesangial cell activation and proliferation through EGFR signaling , Kidney Int: 2026
Sanchez-Russo L, Vasquez-Rios G, Campbell KN. Podocyte-Targeted Therapy in Focal Segmental Glomerulosclerosis: Insights From a Phase 2 Trial of TRPC6 Inhibition , Am J Kidney Dis: 2026